Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Stirling

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|November 1, 2014
The influence of particle size and static magnetic fields on the uptake of magnetic nanoparticles into three dimensional cell-seeded collagen gel culturesEmily E L Lewis, Hannah W Child, Andrew Hursthouse, et al.
Pancreas|January 1, 2009
Antiproliferative effects of CC-8062 and CC-8075 in pancreatic cancer cellsPetros X E Mouratidis, Kay W Colston, Jake Blake Bartlett, et al.
Frontiers in Immunology|August 15, 2022
Pericyte derived chemokines amplify neutrophil recruitment across the cerebrovascular endothelial barrierEliza Gil, Cristina Venturini, David Stirling, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2013
Elucidating the function of penetratin and a static magnetic field in cellular uptake of magnetic nanoparticlesSuman Chaudhary, Carol Anne Smith, Pablo Del Pino, et al.
Cell Communication and Signaling : CCS|May 22, 2026
KTX207-mediated PDE4D degradation disrupts tumour cell migration, invasion, and angiogenic potentialAlina Zorn, Yi Zhao, Aoife Giblin, et al.
ACS Nano|September 8, 2016
A Quiescent, Regeneration-Responsive Tissue Engineered Mesenchymal Stem Cell Bone Marrow Niche Model via Magnetic LevitationEmily Elizabeth Louise Lewis, Helen Wheadon, Natasha Lewis, et al.
Blood|December 24, 2005
Thalidomide derivative CC-4047 inhibits osteoclast formation by down-regulation of PU.1Gülsüm Anderson, Margarete Gries, Noriyoshi Kurihara, et al.
Journal of the American Chemical Society|March 16, 2010
Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatinSarah D Brown, Paola Nativo, Jo-Ann Smith, et al.
British Journal of Pharmacology|June 30, 2026
The selective degradation of PDE4B shortform, using a PROTAC, leads to inhibition of several hallmarks of cancer in HCT116 cellsAlina Zorn, John Daniel Pediani, Madihah Hussain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Combining agents that target the tumor microenvironment improves the efficacy of anticancer therapyJoseph A Blansfield, Diana Caragacianu, H Richard Alexander, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|November 1, 2014
The influence of particle size and static magnetic fields on the uptake of magnetic nanoparticles into three dimensional cell-seeded collagen gel culturesEmily E L Lewis, Hannah W Child, Andrew Hursthouse, et al.
Pancreas|January 1, 2009
Antiproliferative effects of CC-8062 and CC-8075 in pancreatic cancer cellsPetros X E Mouratidis, Kay W Colston, Jake Blake Bartlett, et al.
Frontiers in Immunology|August 15, 2022
Pericyte derived chemokines amplify neutrophil recruitment across the cerebrovascular endothelial barrierEliza Gil, Cristina Venturini, David Stirling, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2013
Elucidating the function of penetratin and a static magnetic field in cellular uptake of magnetic nanoparticlesSuman Chaudhary, Carol Anne Smith, Pablo Del Pino, et al.
Cell Communication and Signaling : CCS|May 22, 2026
KTX207-mediated PDE4D degradation disrupts tumour cell migration, invasion, and angiogenic potentialAlina Zorn, Yi Zhao, Aoife Giblin, et al.
ACS Nano|September 8, 2016
A Quiescent, Regeneration-Responsive Tissue Engineered Mesenchymal Stem Cell Bone Marrow Niche Model via Magnetic LevitationEmily Elizabeth Louise Lewis, Helen Wheadon, Natasha Lewis, et al.
Blood|December 24, 2005
Thalidomide derivative CC-4047 inhibits osteoclast formation by down-regulation of PU.1Gülsüm Anderson, Margarete Gries, Noriyoshi Kurihara, et al.
Journal of the American Chemical Society|March 16, 2010
Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatinSarah D Brown, Paola Nativo, Jo-Ann Smith, et al.
British Journal of Pharmacology|June 30, 2026
The selective degradation of PDE4B shortform, using a PROTAC, leads to inhibition of several hallmarks of cancer in HCT116 cellsAlina Zorn, John Daniel Pediani, Madihah Hussain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Combining agents that target the tumor microenvironment improves the efficacy of anticancer therapyJoseph A Blansfield, Diana Caragacianu, H Richard Alexander, et al.
Pageof 6